Internet Software Company

MedAware Systems, Inc.


Funding Goal $2,000,000
Funding Raised So Far $2,000,000
Funding Commitments $0
Funding Remaining $0
Funding Type Common Equity
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Company Overview

MedAware Systems is a next generation medical data and analytics company that solved the problem of rapid access and analysis of all available data from clinical trials research, regulatory event reporting databases, and social media.

MedAware Systems is a growth-stage company that rapidly ingests 100% of medical research and post market surveillance data to determine the safety and efficacy of medical products. We serve a $500+ billion medical device market and a $1+ Trillion Pharma market worldwide.

MedAware Systems created a patent-pending combination of AI and human intelligence (Advanced Intelligence™) to modernize how published medical science and post market surveillance data are accessed and analyzed.

Our Science of Health Informatics (SOHInfo) application rapidly and accurately collects, curates, and analyzes available safety and efficacy data for drugs, devices, diseases, or medical conditions, granular to specific patient cohorts and application settings.

The Company’s revenue model consists of three closely related services that provide unparalleled business and scientific insight and understanding through the analysis of massive data sets.

Literature and Event Surveillance (subscription service) – Proprietary, AI-Based surveillance software scrapes government event-reporting databases and automatically identifies relevant published articles from the published medical literature. Surveillance of Social Media is also included. Customers instantly access complete intelligence on reported events (malfunction, injury, and death) for their and their competitors’ products.

Data Service (subscription service) – Our AI-Based literature curation process identifies every relevant article (hundreds to tens-of-thousands) and extracts all the data contained in them to create massive analytic databases. Customers have the entirety of available evidence on safety and efficacy for theirs and their competitors’ products.

Meta-Analysis Reports (project service) – Best-in-class meta-analyses, powered by the most complete and comprehensive data available, are rapidly delivered. These reports are interactively managed to provide for customer inputs throughout the process.

lock icon

Invest in Company

Sign up or log in now to unlock profile details and access financials, company documents, and invest in companies.

Business Summary

Company Age
Prior Year Revenue
Current Year Revenue
Next Year Revenue


Science of Health Informatics (SOHInfo) Application

Based on the life’s work of Founder and Chief Science Officer, Dr. Zung Vu Tran, one of world’s leading medical bio-statisticians, this subscription-based and custom report service will eliminate today’s time-consuming and inaccurate keyword searches with precise database queries based on patient specific, disease specific filters, and treatment specific filters.

The Company provides accurate analysis of data across tens, hundreds, or thousands of studies, and reports that information in a standardized and quickly understood format, at a button click.

The end result is that users have the ability to “read” tens, hundreds, or thousands of research studies in less than a minute. The reports generated offer the most comprehensive and granular scientific evidence on the efficacy of disease treatment for the specific patient as well as evidence of safety and efficacy.


Dr. Zung Vu Tran
Chief Science/Scientist
Dr. Z......

Dr. was recently Research Professor of Biostatistics, Colorado School of Public Health, and Clinical Professor of Pediatrics, School of Medicine, University of Colorado, Anschutz Medical Campus. He has also served as Interim Director, Biostatistics & Data Management Core, University of Colorado Cancer Center, and Scientific Director, Biostatistics & Data Management Core, Children’s Hospital of Philadelphia.

Dr. brings over 30 years’ experience in pharmaceutical and medical device industry settings. He is recognized as a leading authority in meta-analysis methodology. As a pioneer in this science of data extraction, integration and analysis, he was the first to publish a meta-analysis in the prestigious Journal of the American Medical Association. Dr. was also the first scientist to receive a NIH R01 grant for developing and applying meta-analysis methodology. He specializes in the design and analysis of clinical trials, and management of large research databases.

Michael Willis
Chief Executive Officer
Michael W......

Michael has served in leadership positions for technology companies for over 30 years and has considerable experience and expertise developing technology products and services for a variety of markets. With a focus on product development, sales, marketing, and customer support he has built successful companies and led them to exit strategies that brought considerable value to investors and other stakeholders.

He was CEO at publicly traded Tombstone technologies; President of Digital Creators, which was acquired by TeleTech; Group Vice President for Production and Development for Jones Digital Century, a division of Jones Intercable, then the 5th largest cable company in the US; and the Vice President for Production for Philips Interactive Media, a division of Philips Electronics.

Neil A. Cox
Chief Financial Officer
Neil A......

Neil has more than three decades experience in the securities and financial industry. He brings a solid understanding of acquisitions, strategic planning, private and public financing.

He was the founder and served as CFO for Tombstone Technologies, a publicly traded software company developing SaaS software systems for the printing industry and acquired by Hunt Global Resources in 2010.

Neil founded, served as CFO and was instrumental in the financing and guidance process in making the company become publicly traded. The software company helped pioneer computerized medical records on the Internet. Its software was leading edge by using an interactive website that allowed for developing complete medical histories viewable on demand by health care providers.

Neil worked as an Investment Banker and was the owner of Rocky Mountain Securities & Investments, Inc. for over 20 years.

Top 10 Tips for Entrepreneurs Seeking Funding

Users who follow these tips increase their fundraising odds substantially.

  • Complete Your Funding Profile
    • Complete your funding profile with all sections filled, including your products and services, a complete management team with headshots, and slideshow with product images.
  • Complete a Business Plan (Optional)
    • Complete a Business Plan in EquityNet and refine your financial projections using the benchmarking alerts in the Business Plan Analysis report.
  • Upload Important Investment Documents
    • Upload and present any other important investment documents such as pitch decks, financial statements, and offering materials.
  • Use EquityNet Crowdcast
    • Use the EquityNet Crowdcast system to automatically email invitations to your contacts in order to build additional exposure for your company.
  • Construct Concise Introductory Messages
    • Construct and send a concise introductory message to investors, including primary reasons why they should want to invest such as KPIs, expected returns, and forecasted revenue.
  • Be Proactive in Messaging Investors
    • Be proactive in messaging many investors and include a simple way for them to connect with you for a web meeting or call, such as a Calendly link.
  • Use the Activity System
    • Use the Activity system to track interested investors, and send prompt follow-up messages to investors who viewed your profile or showed interest.
  • Prepare for Due Diligence
    • Prepare for due diligence questions by interested investors and use your Business Plan and investment documents to satisfy such requests.
  • Keep Your Funding Profile Updated
    • Keep your funding profile updated with new funding raised/committed and message interested investors with any new milestones achieved.
  • Do Not Respond to Unknown Investors
    • Do not respond to or engage any parties outside of EquityNet that are not listed as approved investors (this may happen due to your public profile and LinkedIn connections).